Status In progress
Technology type Medicine
Decision Selected
Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in use addressed, and help them make the best use of NHS resources
Process STA
ID number 3941

Project Team

Project lead Michelle Adhemar

Email enquiries

Timeline

Key events during the development of the guidance:

Date Update
08 April 2022 Following a routing challenge raised by the company, regarding the Topic Selection Oversight Panel’s decision to route maralixibat as a Single Technology Appraisal instead of as a Highly Specialised Technology, the start of this appraisal is therefore delayed. The timelines for this appraisal will be confirmed once NICE has considered this challenge.
14 March 2022 Awaiting development. Status change linked to Topic Selection Decision being set to Selected
14 March 2022 Topic selection
15 December 2021 (10:00) Scoping workshop
03 November 2021 - 01 December 2021 Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators
03 November 2021 In progress. Scoping commenced

For further information on our processes and methods, please see our CHTE processes and methods manual